Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing …SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.3. Segmentation: To achieve reliable radiomic models in oncology, robustly and precisely delineating lesions is essential. However, traditional manual segmentation usually takes a very long time to perform, generates interobserver variability, and requires the involvement of experienced radiologists for analysis.zhe-sheng chen. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University. newyork, United States. Specialty Chief Editor. Cancer Cell Signaling.Introduction. It has been estimated that breast cancer surpassed lung cancer as the first cause of global cancer incidence in females, with 2,261,419 new cases in 2020 ().Moreover, breast cancer is the fifth leading cause of cancer death in females and also a considerable cause of cancer death in males worldwide (1, 2).The incidence rate …Introduction. Glioma is the most common neuroepithelial tumor of the cerebral nervous system ().Ki-67 labeling index (LI) is a nuclear antigen expressed only by proliferating cells ().Previous studies showed that Ki-67 LI was one of the vital biological behavior biomarkers in glioma and correlated with glioma grading and prognosis (3, …Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, …This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …Frontiers in Cancer Science 2023 · Date: 06 November 2023 · Time: 09:00 AM · Venue: National University of Singapore University Cultural Centre 50 Kent Ridge&n...Frontiers in Oncology. Published by Frontiers. Online ISSN: 2234-943X. Disciplines: Geriatrics and Gerontology. Journal website Author guidelines. Top read articles. 211 reads in the past...These were assessed using the American Society of Clinical Oncology and the American College of Pathologist guidelines, employing immunohistochemical methods (26, 27). sTIL levels, classified as low, intermediate, or high (0-10%, 11-39%, and ≥40%, respectively), were determined based on recommendations from previous research (16, …Currently, the main strategies in cancer immunotherapy include tumor vaccines, adoptive cellular immunotherapy (ACI), and immune checkpoint blockade (ICB) therapy ( 19 – 21 ). However, immune drugs alone are not effective for all patients. Drug resistance or adverse effects, including skin rashes, itching, diarrhea, pneumonia, and thyroid ...Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, ranking among the top journals in the category of oncology.The Nutritional Science Research Group issues a quarterly electronic newsletter, Nutrition Frontiers, that highlights emerging evidence linking diet to ...Minimally Invasive Therapies and Molecular Mechanisms Related to Recurrence in Hepatobiliary and Gastric Cancers. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of hepato pancreatic biliary neoplasia.Quan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Frontiers in Cancer Science 2023 · Date: 06 November 2023 · Time: 09:00 AM · Venue: National University of Singapore University Cultural Centre 50 Kent Ridge&n...bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.These were assessed using the American Society of Clinical Oncology and the American College of Pathologist guidelines, employing immunohistochemical methods (26, 27). sTIL levels, classified as low, intermediate, or high (0-10%, 11-39%, and ≥40%, respectively), were determined based on recommendations from previous research (16, …If you’re in the market for a capable and reliable off-road vehicle, the Nissan Frontier 4×4 is an excellent choice. With its rugged design and powerful performance, it’s no wonder...May 10, 2023 · Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ). Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). The radiomics model generated an AUC of 0.722 ( Figure 6C) and 0.706 ( Figure 6D) for HER2 and Ki-67 in the validation cohort, respectively, which was slightly lower than those for ER and PR. Those results suggest that all four models are effective in predicting the molecular expression of BC.Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.Frontiers in Oncology publishes high-quality research on all aspects of cancer, from basic science to clinical applications. It has a fast and rigorous peer review process, a high impact factor and cite score, and a large network of editors and reviewers.This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 …Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 …Learn how to prepare and submit your manuscript to Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the article types, templates, language editing, style, keywords, and other general standards for publication.As an oncology nurse, staying up-to-date with the latest advancements and best practices in your field is essential. Continuing education not only helps you enhance your knowledge ...Abbreviation: FRONT ONCOL. ISSN: 2234-943X. eISSN: 2234-943X. Category / Quartile: ONCOLOGY - SCIE (Q2) WoS Core Citation Indexes: SCIE - Science Citation Index …Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.Given the effective heating ability to moderate temperatures, the improved tumor perfusion, and ability to increase drug absorption, mEHT is a safe and ...Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).Scope. The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, …Aims and scope. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis ...The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ...A recent retrospective analysis on 152 advanced OSCC patients examined the outcome of cancer therapy and the incidence of tumor recurrence after PBM (660 nm, 40 mW, 10 J/cm 2) for the prevention of OM. Results showed that prophylactic PBM did not influence treatment outcome of primary cancer, recurrence, the development of new primary tumors ...Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ...Chronic Stress Promotes Cancer Development. Stress is an inevitable part of life. Chronic stress on account of reasons like adversity, depression, anxiety, or loneliness/social isolation can endanger human health. Recent studies have shown that chronic stress can induce tumorigenesis and promote cancer development.ISSN 2234-943X (Online) | Frontiers in oncology. Skip to main content. Leave this field blank . Log In; Automatic login IP; PUBLISHERS' AREA DISCOVER ISSN SERVICES SEARCH OPEN ACCESS RESOURCES KEEPERS ... Frontiers. CLOCKSS Archive. 2011. 2024. 10/05/2024. 1 to 14. Preserved. Scholars Portal. 02/05/2024. Preserved : …Title proper: Frontiers in oncology. Abbreviated key-title: Front. oncol. Original alphabet of title: Basic roman. Publisher: Lausanne: Frontiers Media S.A., 2011- Dates of …Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.The best modem for Frontier DSL is the Actiontec 300 Mbps, a Frontier-compatible modem with rating of four out of five stars on Amazon.com. Other Frontier-compatible modems include...Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Frontiers in Oncology publishes high-quality research on all aspects of cancer, from basic science to clinical applications. It has a fast and rigorous peer review process, a high impact factor and cite score, and a large network of editors and reviewers.This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.The abbreviation of the journal title "Cancer research frontiers" is "Cancer Res. Front.". It is the recommended abbreviation to be used for abstracting, ....May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.Reviews should present a complete overview of the state of the art (and should not merely summarize the literature), as well as discuss the following: 1) Different schools of thought or controversies, 2) Fundamental concepts, issues, and problems, 3) Current research gaps, 4) Potential developments in the field.» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,4163 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. The Gastrointestinal Cancers: Colorectal Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. Even though the molecular machinery triggering and sustaining colorectal carcinogenesis and the morphogenetic pathways leading ...1 Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China; 2 School of Life Science, University of Chinese Academy of Sciences, Beijing, China; 3 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China; 4 Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China; 5 …Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,4163 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ...AI refers to the ability of application machines to imitate humans or human brain functions to learn and solve problems ( 13 ). It has been more than 60 years since John McCarthy put forward the concept of AI in 1956. Over the past ten years, AI technology has made explosive progress.Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical oncology.As an oncology nurse, staying up-to-date with the latest advancements and best practices in your field is essential. Continuing education not only helps you enhance your knowledge ...» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416The association between objective imaging response and first line immune checkpoint inhibitor (ICI) therapy regimes in advanced melanoma remains …Frontiers in Immuno-Oncology. Print Special Issue Flyer. Special Issue Editors. Special Issue Information. Keywords. Published Papers. A special issue of …Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.1 Introduction. The accuracy of radiotherapy is crucial to its therapeutic effects on patients. Patient-specific QA is an important standard process to identify discrepancies between the dose calculated by a treatment planning system (TPS) and that delivered by the treatment machine (1–3).For two-dimensional (2D) or three-dimensional (3D) …4 days ago · Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies.Advances in Clinical Sarcoma Research: Quality of Life in Sarcoma Patients. Alexander Klein. Dimosthenis Andreou. Dorit Di Gioia. 1,876 views. 2 articles. Advances understanding of new diagnostic and therapeutic strategies of surgical relevance that demonstrably impact cancer patient outcomes.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况，以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …1 Introduction. Immune checkpoint molecules play a crucial role in the immune regulation of malignant tumors, and their biological significance is essential for the diagnosis, prognosis, and treatment of tumors ().Checkpoints are located on various immune cells, including T lymphocytes, or on tumor cells, and they function like switch …Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use …Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical oncology.New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.LetPub整理了最新的Frontiers in Oncology 期刊投稿经验， 期刊官方投稿网址，影响因子，审稿周期/时间，研究方向，SCI期刊分区，中国作者发表的文章等信息， ...Scope. The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology. - Prostate cancer. - Bladder cancer.Jul 6, 2023 ... PDF | The latest issue of "Oncology Research" features four review articles that unveil the latest advancements in the field of cancer ...Sep 8, 2022 ... Welcome to this conference regarding cancer research and therapy organized by the Department of Oncology-Pathology.How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.4 days ago · Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Having a Frontier account is essential for managing your internet, TV, and phone services. It’s important to know how to login to your account so you can take advantage of all the ...1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …Frontiers in Oncology has an h-index of 121.It means 121 articles of this journal have more than 121 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each …The main constituents of the ECS are the classical cannabinoid (CB) receptors, such as CB 1 and CB 2, their endogenous ligands (endocannabinoids), and the endocannabinoids’ synthesizing and degrading enzymes. The role of the ECS in cancer is still unclear and its effects often depend on the tumor entity and the expression levels of … Jul 6, 2018 · The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 2
116. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat oncology biology physics (1995) 31(5):1341–6. doi: 10.1016/0360-3016(95)00060-C. CrossRef Full Text | Google ScholarSee all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ...4 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia 5 Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited.zhe-sheng chen. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University. newyork, United States. Specialty Chief Editor. Cancer Cell Signaling.New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Immunobiology and Immunotherapeutics in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Shyam Patel. Anna Aureli. Alessandro Isidori. Claudio Cerchione. 2,536 views. 2 articles. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and ...1 Introduction. The human epidermal growth factor receptor protein tyrosine kinase family, including EGFR and HER2, has emerged as an important therapeutic target for non-small cell lung cancer, breast cancer, and gastroesophageal cancer (1, 2).In NSCLC, EGFR exon 20 insertions mutations account for 1.5-2.5% of all NSCLC, 6% of …Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$. Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... Since then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC …Frontiers | Registration - Frontiers | Peer Reviewed ArticlesSince then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC …Frontiers in Oncology. Published by Frontiers. Online ISSN: 2234-943X. Disciplines: Geriatrics and Gerontology. Journal website Author guidelines. Top read articles. 211 reads in the past...Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Jul 6, 2023 ... PDF | The latest issue of "Oncology Research" features four review articles that unveil the latest advancements in the field of cancer ...Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.PCNSTCL with isolated brain involvement occurred in two of 1,040 patients (0.19%). Out of 11 patients with CNS and systemic disease at presentation, brain involvement was documented in four patients, isolated leptomeningeal disease was diagnosed in four patients, combined parenchymal and leptomeningeal disease was detected in two …Institute of Molecular Pathology Biomarkers, University of Extremadura. Cáceres, Spain. Specialty Chief Editor. Pharmacogenetics and Pharmacogenomics.Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …A multidisciplinary team (MDT) in oncology is defined as the cooperation between different specialized professionals involved in cancer care with the overarching goal of improving treatment efficiency and patient care. Head and neck cancer (HNC) involves multiple and biologically distinct diseases that require different therapeutic approaches.penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.Precision Medicine in Oncology. Recent advances in technology have unveiled a tremendous heterogeneity in cancer dysfunctional mechanisms. This gain of knowledge has opened a new era in oncology, which relays on the concept that each tumor is different and should be treated in a specific way depending on its distinctive …Introduction. It has been estimated that breast cancer surpassed lung cancer as the first cause of global cancer incidence in females, with 2,261,419 new cases in 2020 ().Moreover, breast cancer is the fifth leading cause of cancer death in females and also a considerable cause of cancer death in males worldwide (1, 2).The incidence rate …James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.The AA of oncology drugs is traditionally supported by single-arm trials. The emphasis on randomization and control fits the 2-in-1 design well because it is the default feature of any adaptive phase 2/3 trial. Project FrontRunner also proposed a one-trial approach to support both AA and regular approval (RA) in the same phase 3 trial, on top ... Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing on advancements in information in cancer biology. Perhaps key for incorporation of TDM in oncology, are barriers aligned with knowledge . As evidence to support TDM in oncology is largely provided by academic initiatives, the body of literature is affected by factors such as limited funding and time, and may be the reason for a paucity of clinical studies.Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …A multidisciplinary team (MDT) in oncology is defined as the cooperation between different specialized professionals involved in cancer care with the overarching goal of improving treatment efficiency and patient care. Head and neck cancer (HNC) involves multiple and biologically distinct diseases that require different therapeutic approaches.1 Introduction. Immune checkpoint molecules play a crucial role in the immune regulation of malignant tumors, and their biological significance is essential for the diagnosis, prognosis, and treatment of tumors ().Checkpoints are located on various immune cells, including T lymphocytes, or on tumor cells, and they function like switch …Chronic Stress Promotes Cancer Development. Stress is an inevitable part of life. Chronic stress on account of reasons like adversity, depression, anxiety, or loneliness/social isolation can endanger human health. Recent studies have shown that chronic stress can induce tumorigenesis and promote cancer development. michael kattan. Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University. Cleveland, United States. Specialty Chief Editor. Genitourinary Oncology. Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024, About.weixing dai. Shanghai Cancer Center, Fudan University. Shanghai, China. Associate Editor. Gastrointestinal Cancers: Colorectal Cancer. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ... They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.4 days ago · Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Jun 27, 2021 · In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator. To print a Frontier boarding pass, visit the Frontier website and check-in online